Literature DB >> 10231259

Recent advances: hepatology.

M McCarthy1, M L Wilkinson.   

Abstract

Mesh：

Year:  1999        PMID： 10231259      PMCID： PMC1115649          DOI： 10.1136/bmj.318.7193.1256

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  20 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

2.  Successful medical treatment of severely decompensated Wilson disease.

Authors:  E E Santos Silva; J Sarles; J P Buts; E M Sokal
Journal:  J Pediatr       Date:  1996-02       Impact factor: 4.406

3.  Liver transplantation for haemophiliacs with hepatitis C cirrhosis.

Authors:  M McCarthy; E Gane; S Pereira; C J Tibbs; N Heaton; M Rela; H Hambley; R Williams
Journal:  Gut       Date:  1996-12       Impact factor: 23.059

Review 4.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

Review 5.  Vanishing bile duct syndrome in drug-induced liver disease.

Authors:  V J Desmet
Journal:  J Hepatol       Date:  1997       Impact factor: 25.083

6.  A simple genetic test identifies 90% of UK patients with haemochromatosis. The UK Haemochromatosis Consortium.

Authors: 
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

Review 7.  National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C.

Authors: 
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

8.  Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Authors:  T Poynard; P Bedossa; P Opolon
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

9.  An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors.

Authors:  K Ozawa; S Uemoto; K Tanaka; K Kumada; Y Yamaoka; N Kobayashi; T Inamoto; Y Shimahara; K Mori; K Honda
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

10.  Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation.

Authors:  J B Otte; J de Ville de Goyet; E Sokal; D Alberti; D Moulin; B de Hemptinne; F Veyckemans; L van Obbergh; M Carlier; P Clapuyt
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969
View more
  1 in total

1.  Treatment of hepatitis C infection. Review underplayed important public health issues.

Authors:  K Agarwal; D D Jones
Journal:  BMJ       Date:  1999-08-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.